Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Trophos awarded EUR 1 million grant for TRO-40303 in ischemia-reperfusion injury

March 4, 2008

FDA approves supplemental NDA for Abilify in pediatric bipolar disorder

March 4, 2008

New therapeutics for psychiatric disorders described in recent patent literature

March 4, 2008

FDA approves Aloxi injection for prevention of postoperative nausea and vomiting

March 3, 2008

FDA approves Pristiq as therapy for adults with major depressive disorder

March 3, 2008

AstraZeneca submits sNDA for Seroquel XR for major depressive disorder

March 3, 2008

Alpharma submits NDA for Embeda

March 3, 2008

Phase II clinical trial shows efficacy of AL-108 in cognition and memory impairment

March 3, 2008

ZARS is granted marketing authorization for Rapydan in 11 European countries

March 3, 2008

Preclinical profile of GRL-8234 reported by Comentis

March 3, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...